title: Is allogeneic bone marrow transplantation the best treatment for young adult patients with acute myeloid leukemia in first complete remission. The BGMT Group.
authors.affiliation: Bone Marrow Transplant Unit of Bordeaux, France.
authors.forename: J
authors.initials: J
authors.lastname: Reiffers
authors.forename: A M
authors.initials: AM
authors.lastname: Stoppa
authors.forename: F
authors.initials: F
authors.lastname: Rigal-Huguet
authors.forename: M
authors.initials: M
authors.lastname: Michallet
authors.forename: G
authors.initials: G
authors.lastname: Marit
authors.forename: D
authors.initials: D
authors.lastname: Blaise
authors.forename: M
authors.initials: M
authors.lastname: Attal
authors.forename: B
authors.initials: B
authors.lastname: Corront
authors.forename: P
authors.initials: P
authors.lastname: Cony-Makhoul
authors.forename: J A
authors.initials: JA
authors.lastname: Gastaut
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012008:Recurrence; D012074:Remission Induction; D014184:Transplantation, Homologous
chemical_list: D003561:Cytarabine; D003630:Daunorubicin